Metforminobservational2022

Molecular docking analysis of metformin analogues with GSK-3β.

Bioinformation

confidence

Key findings

Molecular docking analysis of four metformin analogues with GSK3β; no clinical or biological endpoints reported.

Population: In silico molecular docking study
Blinding: not_reported
Controls: not_reported
Drug class: biguanide

Full abstract

We report the molecular docking analysis of four analogues of metformin [1-Carbamimidoyl-1,2-dimethylguanidine hydrochloride, Metformin hydrochloride, N1,N1-Dimethyl-N5-methylbiguanide hydrochloride, and N1,N1,N5,N5-Tetrakis (methyl-biguanide hydrochloride] with GSK3.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.